Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05946252
Other study ID # IEU_SYY_1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 1, 2023
Est. completion date January 5, 2024

Study information

Verified date January 2024
Source Izmir University of Economics
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to determine the acute effects of motor imagery exercises on fetal heart rate, uterine contractions, maternal heart rate, blood pressure, oxygen saturation and well-being in high-risk pregnant women.


Description:

Bed rest is often recommended in high-risk pregnant women to prevent complications from reaching dangerous levels. Pregnant women recommended bed rest can benefit from exercise in order to overcome this process more easily, to reduce the negative consequences of inactivity and to prevent possible risks. However, there may be differences between the view of high-risk pregnant women and the view of healthy pregnant women. Motor imagery refers to a mental process in which an individual mentally imagines that movement without actually eliciting an active movement. Studies have shown that similar brain regions are activated during movement performance and movement imagery. It has been reported in the literature that progressive relaxation exercises performed under mental/motor imagery guidance in healthy pregnant women and pregnant women lead to an improvement in maternal anxiety, stress and fetal attachment scales and a decrease in maternal systolic/diastolic blood pressure. However, as far as the investigators know, there is no study that applies the exercise protocol that can be given to healthy pregnant women to high-risk pregnant women with motor imagery and examines acute responses on fetal and maternal parameters.


Recruitment information / eligibility

Status Completed
Enrollment 76
Est. completion date January 5, 2024
Est. primary completion date October 2, 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: Risky pregnant women who have completed the 12th week of pregnancy, received inpatient treatment and have any of the following risk factors will be included in the study: - Pregnant women who are at risk for obstetric outcomes such as cervical insufficiency, multiple pregnancy and uncontrolled gestational diabetes, and physical activity restriction is recommended due to these conditions, and exercise is contraindicated, - Pregnant women with a maternal body mass index above 30, which causes them to be physically inactive Exclusion Criteria: - Pregnant women who are at risk for obstetric outcomes such as gestational diabetes mellitus and pregnancy-induced hypertension, but physical activity is recommended - Pregnant women with severe cardiovascular, pulmonary and systemic disorders - Pregnant women with psychological seizure disorders - Pregnant women who do not have any mental problems that prevent cooperation and understanding - Pregnant women with any medical condition that prevents the safe and effective implementation of interventions. - Pregnant women in other high-risk groups (such as early membrane rupture, placenta previa, preeclampsia) that may have early intervention in terms of obstetric outcomes.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Motor imagery
Motor imagery will be performed according to the PETTLEP (Physical,Environment,Task,Time,Learn,Emotion,Perspective) model for 15 minutes. To imagine walking activity in different environments (seaside, beach, walking path). The rest activity will be imagined by sitting on a bench. Upper extremity strengthening exercises with dumbbells, lower extremity strengthening exercises with elastic band and trunk-oriented bridging, posterior pelvic tilt and table top stabilization exercises will be visualized. The rest activity will be imagined by sitting on a bench. Imagination will end with homecoming and domestic activities.
Diaphragmatic breathing
Diaphragmatic breathing will be shown to pregnant women in the supine position, eyes closed, with one hand on the chest and the other hand on the abdomen. This practice will last for five minutes.

Locations

Country Name City State
Turkey Health Sciences University Izmir Tepecik Education and Research Hospital Gynecology and Obstetrics Clinic Izmir

Sponsors (1)

Lead Sponsor Collaborator
Izmir University of Economics

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maternal self well-being Well-being will be assessed on a numbered classification scale-11. '0' indicates worse self well-being, '10' indicates excellent self well-being. at baseline
Secondary Maternal self well-being Well-being will be assessed on a numbered classification scale-11. '0' indicates worse self well-being, '10' indicates excellent self well-being. immediately after intervention
Secondary Maternal heart rate Heart rate measurements will be made with an arm type digital sphygmomanometer. at baseline
Secondary Maternal heart rate Heart rate measurements will be made with an arm type digital sphygmomanometer. in the 7th minutes of the intervention
Secondary Maternal heart rate Heart rate measurements will be made with an arm type digital sphygmomanometer. immediately after intervention
Secondary Maternal blood pressure (systolic pressure) Blood pressure measurements will be made with an arm type digital sphygmomanometer.
Systolic blood pressure and diastolic blood pressure will be assessed.
at baseline
Secondary Maternal blood pressure (systolic pressure) Blood pressure measurements will be made with an arm type digital sphygmomanometer.
Systolic blood pressure and diastolic blood pressure will be assessed.
in the 7th minutes of the intervention
Secondary Maternal blood pressure (systolic pressure) Blood pressure measurements will be made with an arm type digital sphygmomanometer.
Systolic blood pressure and diastolic blood pressure will be assessed.
immediately after intervention
Secondary Maternal blood pressure (diastolic pressure) Blood pressure measurements will be made with an arm type digital sphygmomanometer.
Systolic blood pressure and diastolic blood pressure will be assessed.
at baseline
Secondary Maternal blood pressure (diastolic pressure) Blood pressure measurements will be made with an arm type digital sphygmomanometer.
Systolic blood pressure and diastolic blood pressure will be assessed.
in the 7th minutes of the intervention
Secondary Maternal blood pressure (diastolic pressure) Blood pressure measurements will be made with an arm type digital sphygmomanometer.
Systolic blood pressure and diastolic blood pressure will be assessed.
immediately after intervention
Secondary oxygen saturation Finger type pulse oximeter will be attached and peripheral oxygen saturation will be monitored. at baseline
Secondary oxygen saturation Finger type pulse oximeter will be attached and peripheral oxygen saturation will be monitored. in the 7th minutes of the intervention
Secondary oxygen saturation Finger type pulse oximeter will be attached and peripheral oxygen saturation will be monitored. immediately after intervention
Secondary Fetal Heart Rate Fetal heart rate will be monitored with a cardiotachometer (Philips Avalon Fetal Monitor). at baseline
Secondary Fetal Heart Rate Fetal heart rate will be monitored with a cardiotachometer (Philips Avalon Fetal Monitor). in the 7th minutes of the intervention
Secondary Fetal Heart Rate Fetal heart rate will be monitored with a cardiotachometer (Philips Avalon Fetal Monitor). immediately after intervention
Secondary Uterine contractions severity Uterine contractions severity will be monitored with a cardiotachometer (Philips Avalon Fetal Monitor). at baseline
Secondary Uterine contractions severity Uterine contractions severity will be monitored with a cardiotachometer (Philips Avalon Fetal Monitor). in the 7th minutes of the intervention
Secondary Uterine contractions severity Uterine contractions severity will be monitored with a cardiotachometer (Philips Avalon Fetal Monitor). immediately after intervention
See also
  Status Clinical Trial Phase
Completed NCT03651843 - Perception of Risks Into Work During Pregnancy Among Post-partum Women in the Lille Metropolis
Active, not recruiting NCT05656352 - Validation of a Non-invasive Hemoglobin Measurement Device in Pregnancy and Postpartum in Kenya, Pakistan, and Zambia
Not yet recruiting NCT06430853 - Psychobiological Interventions in Pregnancy N/A
Completed NCT05316415 - The Effects of Music on the Anxiety and Sleep Quality of Pregnant Women on Bed Rest for a High-risk Pregnancy N/A
Not yet recruiting NCT03985618 - The MODE Trial: Planned Caesarean Section Versus Induction of Labour for Women With Class III Obesity N/A
Completed NCT02008097 - Clinical Benefits of B-Flow Ultrasound N/A
Recruiting NCT05922033 - Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER) Phase 4
Completed NCT03413631 - A Prenatal Mentalization-focused 4D Ultrasound and a Pregnancy Diary Intervention for Substance-abusing Women N/A
Not yet recruiting NCT05388643 - Early Detection of Gestational Diabetes Mellitus in Pregnancy N/A
Not yet recruiting NCT05317585 - Continuous Glucose Monitor Use in Pregnancy N/A
Recruiting NCT04861103 - Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH) Phase 4
Completed NCT03334149 - Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of Hypertension N/A
Completed NCT03646487 - A Randomized Placebo Controlled Pilot Study of Probiotic Supplementation in At-risk Pregnant Women N/A
Recruiting NCT05198206 - Pregnant Women With Pulmonary Hypertension in China
Recruiting NCT05739123 - Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
Recruiting NCT05807256 - Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases
Completed NCT04874285 - Use of Dietary Supplements in Patients at Risk of Abortion Treated With Progesterone. N/A
Not yet recruiting NCT05662462 - Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching N/A
Recruiting NCT03975894 - TAPS2 Transfusion Antenatally in Pregnant Women With SCD Phase 2
Recruiting NCT05597943 - mHealth Smartphone App and Postpartum Glucose Intolerance for Patients With GDM N/A